Treatment of Refractory Acute Graft-Versus-Host Disease by Sequential Infusion of Allogenic Mesenchymal Stem Cell.

NCT01956903 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Chronic Graft-Versus-Host Disease

Interventions

GENETIC: Allogenic Mesenchymal Stem Cell

Sponsor

Grupo Espanol de trasplantes hematopoyeticos y terapia celular